Published in Biotech Law Weekly, November 18th, 2005
"The treatment resulted in sustained and meaningful functional improvement that makes a difference in the daily lives of stroke patients and the people who care for them," said Allison Brashear, MD, professor and chairman of neurology at Wake Forest University Baptist Medical Center.
The findings were presented at the 2005 Annual Meeting of the American Association of Physical Medicine and Rehabilitation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.